Loading company…
Unchain Bio helps regenerative medicine companies commercialize therapies through Japan’s regulatory pathways.
Founded in 2026 in London by Pedro Henrique Pinto Azevedo, Unchain Bio is a biotechnology commercialization platform. It helps regenerative medicine companies bring therapies to patients through Japan’s regulatory pathways. In June 2026, it raised USD 100,000 in pre-seed funding from Antler.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in